TGFBR1 and esophageal squamous cell carcinoma: In this study, we further validated that both the use of an inhibitor of TGFβR1 (SB431542) and the knockdown of TGFβR1 ameliorated the cisplatin resistance of ESCC cells induced by M2-TAMs.